News
Turkish Cargo uses passenger aircrafts of Turkish Airlines for Medical cargo
Turkish Cargo started to operate cargo flights with Turkish Airlines’ passenger aircrafts in addition to its 25 high capacity freighters in order to prevent any mishaps in the supply chain of medical cargo of vital importance.
Flying the first of...
News
Quidel’s Lyra SARS-CoV-2 Assay Receives Authorization for Expanded Use for Molecular Detection of COVID-19
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel’s Lyra® SARS-CoV-2 Assay has received expanded Emergency Use Authorization (EUA) claims from the Food and Drug Administration (FDA)...
News
MIG USA, a North Carolina Company, to Bring Needed Relief Through the Provision of Coronavirus Test Kits
MIG USA, LLC , a High Point, North Carolina company having focus in the biotechnology, pharmaceutical, and clinical research sectors, along with its corporate partner, have acquired the exclusive rights to manufacture and distribute a rapid-result coronavirus test kit,...
News
Pfizer Wins New Pediatric Approval for Atopic Dermatitis Ointment Eucrisa
The U.S. FDA greenlit a new pediatric approval for Pfizer’s Eucrisa ointment in the treatment of mild-to-moderate atopic dermatitis, an inflammatory skin disease that impacts a large number of pre-adolescent children.
Pfizer announced late Monday that the FDA approved a...
News
OliX Pharmaceuticals Advances RNAi Approaches to Target Highly Conserved Regions of Coronavirus RNAs
OliX Pharmaceuticals, Inc. , a leading developer of RNA interference (RNAi), announced that it will leverage previous preclinical research for developing siRNA therapeutics in treating respiratory illnesses to investigate a path forward for developing a COVID-19 therapy.
COVID-19 belongs to...
News
Univercells launches new CDMO for cell and gene therapy sector
The company’s new CDMO, Exothera, has been created to help the cell and gene therapy sector increase its capacity, and also boost its bioprocessing expertise. The CDMO will create bespoke bioproduction support programmes for manufacturers to achieve successful market...
News
CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop Probody T-Cell Engaging Bispecific Therapies
CytomX Therapeutics, Inc and Astellas Pharma Inc. announced they have entered into a strategic collaboration agreement focused on the discovery, research, development and commercialization of novel T-cell engaging bispecific antibodies targeting CD3 and tumor cell surface antigens for the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read